Allied Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Michael Moses
- Full Time Employees
- 150
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1405 St. Paul Street Kelowna BC Canada V1Y 2E4
- IPO Date
- Aug 15, 2019
- CIK
- 0001575295
- Website
- allied.health
- Similar Companies
- Business
- Allied Corp (OTCQB: ALID) produces and supplies pharmaceutical-grade medical cannabis flower and related products from its cultivation operations in Colombia to global pharmaceutical partners and medical markets. The company offers premium sun-grown cannabis flower meeting European Pharmacopeia and TGO93 standards, with proprietary genetics through exclusive strains launched in partnerships; hemp-based CBD natural health products; cannabis-infused beauty, skincare, foods and beverages; and developmental candidates ALID 10 and ALID 11 targeting post-traumatic stress disorder via 5-HT2 receptor modulation. Allied operates segments in Colombia for cultivation and Canada for management, shipping over 5,000 kg to markets including Australia, Switzerland, Portugal, UK, Germany and Poland; it maintains ICA BPA (GAP) and GACP certifications, plus EU-GMP compliant processing via partners like Blossom Genetics in Portugal. Founded in 2013 as Cosmo Ventures Inc. and renamed Allied Corp in 2019, the company is headquartered at 460 Doyle Ave, Suite 200, Kelowna, British Columbia V1Y 0C2, Canada. Recent developments include a 5-year exclusive EUR 15.3 million supply agreement signed October 2024 with CanPoland for 1.05 tons of Colombian flower annually to Poland, featuring three proprietary strains; first and second deliveries to Germany in July and October 2025 amid accelerating European demand; GACP certification achievement in June 2025 supporting international expansion; leadership team strengthening in February 2025 for global execution; a forward purchase deal with a Sao Paulo distributor for US$147,000 monthly oncology products; and a joint venture with Blueberries Medical for psychoactive/non-psychoactive derivatives leveraging extraction expertise.
Allied Corp Announces Signing of Supply Contracts of 85,000, 40,000 and 24,000 Kilograms for the 2022 Calendar Year
Allied Corp Announces Approval of Research and Plant Breeding License for Psychoactive and Non-Psychoactive Cannabis in Colombia
Allied Corp Provides Results of Recent Third Party Audit Confirming Production Costs and Optimization of Production
Allied Corp. Announces Approval of Second CBD Isolate Import Permit for Australia and Submits Application for the Import of Dried Cannabis
Allied Corp Provides Update Regarding Nevada Building and Option to Purchase Nevada State License
Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process
Allied Corp. Initiates Additional Shipment of 200kgs of CBD Distillate From Colombia to Nevada, United States
Allied Corp. Signs Additional Supply Contracts for the Export of Cannabis Flower and CBD Isolate From Colombia to Australia
Allied Corp Initiates Additional Commercial CBD Shipment From Colombia Destined for Colorado, United States
Allied Corp Completes Commercial CBD Shipments From Colombia Into Australia
Allied Corp Commends the Colombian Authorities for Approving the Export of Dried Cannabis Flower From Colombia
Allied Corp Initiates Commercial CBD Shipments From Colombia Into Peru and Europe
Allied Corp Receives Import Approvals for CBD Sales to Australia and Peru
Allied Corp Completes Commercial CBD Shipment From Colombia Into the United States
Allied Corp Strengthens Financial Team Through Signing with Boustead Securities LLC
Allied Corp Expands Cannabis Production and Inventory Capacity
Allied Sells Out First Colombian Harvest and Begins to Rapidly Scale Colombian Production
Allied Corp. Announces Launch of Allied Corp Brands E-commerce Portal with Tactical Relief™, Equilibrium Bio™ and MaXXa™ branded products now for sale in the United States
Allied Corp. Announces Clearance From the Colombian Authorities to Export Cannabis Products To Second International Market
Allied Corp Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities